Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Pfizer Covic-19 vaccine
Pfizer Covid-19 vaccine - Credit: Carlosviv / DepositPhotos - License: DepositPhotos
Health
Coronavirus
Health Council
Covid-19
SARS-CoV-2
Pfizer
Biontech
vaccine
vaccination
elderly
healthcare workers
Hugo de Jonge
Ministry of Public Health Welfare and Sports
Friday, 25 December 2020 - 08:34

Share this article:

NL will vaccinate care workers first despite advice to prioritise elderly

The Health Council advised to use the Pfizer/BioNTech vaccine to inoculate the elderly against the coronavirus. This is the first vaccine that will be available, with the Netherlands starting vaccinations on January 8. The government is sticking to its decision to first give the vaccine to care workers, Minister Hugo de Jonge of Public Health said in a letter to parliament, NOS reports.

According to the Health Council, people over the age of 60 are at the greatest risk of serious illness or death from the coronavirus. "The effectiveness of this vaccine is above expectations in the elderly. That is why the council advises to reserve as much of this vaccine as possible for this group and to start the vaccination with the elderly," the Health Council said.

A limited part of the Pfizer vaccine can be used to inoculate healthcare workers to protect vulnerable elderly and to guarantee the continuity of care, the Council said. The Council thinks healthcare workers should be given priority with the AstraZeneca vaccine, which is expected at the end of the first quarter next year.

Despite this advice, the government is sticking to its plan to give the first vaccines to nursing home employees, employees in disabled care, and the district nurses, De Jonge said in a letter to parliament. This decision was made because the vaccine is supplied in large quantities and must be kept cold. This is easier to arrange at a central location, where healthcare workers can go for their shot.

The next deliveries of the vaccine will be reserved for people aged 60 and older, as recommended by the Health Council, De Jonge said.

The Pfizer vaccine was approved for use in the European Union last week. According to the European Medicines Agency, no serious side effects were found and the vaccine is 95 percent effective, including in the elderly and other high risk groups.

More like this

Image
Vials of Covid-19 vaccines produced by Pfizer, Moderna and AstraZeneca. March 21, 2021
Dutch gov't did too little to prevent cronyism in buying Covid vaccines: Court of Audit
Image
Vaccination
Netherlands to start using new HPV vaccine next year
Image
A healthworker looking through a window in Hospital during the coronavirus pandemic.
Five years after first Covid-19 infection Netherlands is even less prepared for pandemic
Image
Vials of Covid-19 vaccines produced by Pfizer, Moderna and AstraZeneca. March 21, 2021
Unvaccinated were twice as likely to die from Covid as vaccinated: Nivel
Make NL Times your top Google source

Follow us:

Latest stories

  • Ronald Koeman resigns as Netherlands head coach after World Cup exit
  • Streaming revenue surpasses traditional TV in the Netherlands for first time
  • Trial over fatal Marken teen collision concludes with eight-week sentence recommendation
  • Disinformation and vaccine hesitancy among top new health risks, says Dutch institute
  • Dutch FA to report online racist abuse of Oranje trio after Morocco defeat

Top stories

  • Ronald Koeman resigns as Netherlands head coach after World Cup exit
  • Eurostar cancels many London-Amsterdam trains after Rotterdam rail fire
  • Morocco fans overjoyed in cities after beating Oranje; Fireworks thrown at Hague police
  • Oranje crash out of World Cup after another penalty shootout heartbreak against Morocco
  • Storm damage claims surge after weekend of severe weather across the Netherlands

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content